Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS2 | P35354 | 15/20 | 0.59 |
| ▸ | PTGS1 | P23219 | 7/20 | 0.59 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.48 |
| ▸ | CA1 | P00915 | 1/20 | 0.47 |
| ▸ | CA2 | P00918 | 1/20 | 0.47 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5202675 | 0.94 | PTGS2 (0.65) | PTGS2PTGS1CYP2C9 | |
| SCHEMBL6885294 | 0.94 | PTGS2 (0.65) | PTGS2PTGS1CYP2C9 | |
| SCHEMBL5202252 | 0.92 | PTGS2 (0.53) | PTGS2PTGS1ALOX5CYP2C9 | |
| SCHEMBL6880090 | 0.92 | PTGS2 (0.53) | PTGS2PTGS1ALOX5CYP2C9 | |
| SCHEMBL6887276 | 0.86 | PTGS2 (0.59) | PTGS2PTGS1CYP2C9 | |
| SCHEMBL5201186 | 0.84 | PTGS2 (0.53) | PTGS2PTGS1CYP2C9 | |
| SCHEMBL5204710 | 0.84 | PTGS2 (0.65) | PTGS2PTGS1ALOX5CA1CA2 | |
| SCHEMBL5204765 | 0.84 | PTGS2 (0.58) | PTGS2PTGS1CYP2C9 | |
| SCHEMBL1382505 | 0.84 | PTGS2 (0.65) | PTGS2PTGS1ALOX5CA1CA2 | |
| SCHEMBL6132473 | 0.84 | PTGS2 (0.67) | PTGS2PTGS1CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1246809-A1 | 5-ARYL-1H-1,2,4-TRIAZOLE COMPOUNDS AS INHIBITORS OF CYCLOOXYGENASE-2 AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | LABORATOIRE THERAMEX (MC) | 2002-10-09 | — | — | EP | claimed |
| WO-2001034577-A1 | 5-ARYL-1H-1,2,4-TRIAZOLE COMPOUNDS AS INHIBITORS OF CYCLOOXYGENASE-2 AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | LABORATOIRE THERAMEX (MC) | 2001-05-17 | — | — | WO | claimed |